Lung adenocarcinoma, the most common histological subtype of non‐small cell lung cancer, continues to pose significant challenges in both prognosis and classification. Contemporary research has ...

We present a case of a female in her late 40s with a 5-year history of well-managed type II diabetes mellitus, systemic hypertension and dyslipidaemia presented with acute severe abdominal pain, ...

Lung adenocarcinoma remains one of the most challenging cancers to diagnose accurately, with pathologists spending countless hours examining tissue samples under microscopes to determine cancer grades ...

Plasma-based next generation sequencing in advanced non-small cell lung cancer (NSCLC): Significance in diagnosis and treatment. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.

New research has revealed that perilipin 2 protein modulates aggressive cancer progression in advanced lung adenocarcinoma, the most common type of lung cancer, by regulating lipid droplet ...

Early-stage non-small cell lung cancer (NSCLC) offers a better prognosis than advanced stages. Staging helps inform treatment by describing your cancer's size, lymph node involvement, and metastasis.

Lung cancer is increasingly affecting non-smoking women in Indian metros, with adenocarcinoma now the dominant subtype.

Bizengri received accelerated approval for NRG1 fusion-positive NSCLC and pancreatic adenocarcinoma, showing ORRs of 33% and 40%, respectively, with varying DORs. Imfinzi significantly improved ...